Suzanne Ildstad - Mar 1, 2023 Form 4/A - Amendment Insider Report for Talaris Therapeutics, Inc. (TALS)

Role: Director
Signature: /s/ Mary Kay Fenton, attorney-in-fact
Stock symbol: TALS
Transactions as of: Mar 1, 2023
Transactions value $: -$59
Form type: 4/A - Amendment
Date filed: 4/7/2023, 04:21 PM
Date Of Original Report: Mar 2, 2023
Previous filing: Apr 7, 2023
Next filing: Apr 7, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TALS	Common Stock	Sale	-$60	-29	0%	$2.05	3.07M	Mar 1, 2023	Direct	F1
holding	TALS	Common Stock						1.2M	Mar 1, 2023	by GRAT
holding	TALS	Common Stock						654K	Mar 1, 2023	See footnote	F2
holding	TALS	Common Stock						654K	Mar 1, 2023	See footnote	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id	Content
F1	This amendment is being filed solely to indicated the sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 11, 2022.
F2	These shares are held in a trust for the benefit of the Reporting Person's son. The Reporting Person's son is co-trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F3	These shares are held in a trust for the benefit of the Reporting Person's daughter. The Reporting Person's daughter is co-trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.